BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Free Report) CEO Lance Alstodt purchased 4,200 shares of BioRestorative Therapies stock in a transaction on Tuesday, July 25th. The stock was bought at an average cost of $2.44 per share, with a total value of $10,248.00. Following the transaction, the chief executive officer now directly owns 184,418 shares […]